https://www.aigom.it/wp-content/uploads/2026/03/ART17.3.png1114700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-03-17 08:26:422026-03-17 08:26:42ADDITION OF CARBOPLATIN TO SEQUENTIAL TAXANE-ANTHRACYCLINE NEOADJUVANT CHEMOTHERAPY IN TRIPLE-NEGATIVE BREAST CANCER: A PHASE III RANDOMIZED CONTROLLED TRIAL.
https://www.aigom.it/wp-content/uploads/2026/03/art10.3.png1079700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-03-10 08:22:402026-03-10 08:22:40TEN-YEAR SURVIVAL AFTER POSTMASTECTOMY CHEST-WALL IRRADIATION IN BREAST CANCER.
https://www.aigom.it/wp-content/uploads/2026/03/ART3.3.png1126700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-03-03 09:12:222026-03-03 09:12:22ADDRESSING COMMON MEDICATIONS THAT INFLUENCE IMMUNOTHERAPY RESPONSE IN SOLID TUMORS.
https://www.aigom.it/wp-content/uploads/2026/03/Screenshot-2026-03-27-105153.png1056749Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-25 09:51:302026-06-30 15:01:5426-27-28 MARZO 2026-NEGRAR DI VALPOLICELLA (VR)-SCUOLA DI METODOLOGIA DELLA RICERCA CLINICA
https://www.aigom.it/wp-content/uploads/2026/02/ART24.2.png1059700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-24 07:47:032026-02-24 07:47:03PALBOCICLIB FOR HORMONE-RECEPTOR POSITIVE, HER2-POSITIVE ADVANCED BREAST CANCER.
https://www.aigom.it/wp-content/uploads/2026/02/ART17.2.png1030700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-17 09:13:392026-02-17 09:13:39TRASTUZUMAB DERUXTECAN PLUS PERTUZUMAB FOR HER2-POSITIVE METASTATIC BREAST CANCER
https://www.aigom.it/wp-content/uploads/2026/02/ART10.2-1.png1154700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-10 08:09:292026-02-10 08:14:33IMMUNE CHECKPOINT INHIBITORS FOR MISMATCH REPAIR-DEFICIENT GASTROESOPHAGEAL ADENOCARCINOMA: OUTCOMES AND FEASIBILITY OF NONOPERATIVE MANAGEMENT AT MAYO CLINIC.
https://www.aigom.it/wp-content/uploads/2026/02/ART3.2.png1172700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-03 08:31:362026-02-03 08:31:36ADJUVANT EPIRUBICIN PLUS CYCLOPHOSPHAMIDE FOLLOWED BY TAXANES WITH OR WITHOUT CARBOPLATIN IN EARLY-STAGE TRIPLE-NEGATIVE BREAST CANCER (RJBC 1501): A RANDOMIZED PHASE III TRIAL.
